Oncology & Cancer

Landmark genetic study better predicts stomach cancer

A research team led by National University Health System (NUHS) and Duke-NUS Medical School has used genomic technologies to better understand intestinal metaplasia (IM), a known risk factor for gastric (stomach) cancer. ...

Diseases, Conditions, Syndromes

PPI-gastric cancer link remains after H. pylori eradication

(HealthDay)—Long-term proton pump inhibitor (PPI) use is associated with increased risk of gastric cancer (GC) even after Helicobacter pylori (HP) eradication therapy, according to a study published online Oct. 31 in Gut.

Medical research

Are stem cells the link between bacteria and cancer?

Gastric carcinoma is one of the most common causes of cancer-related deaths, primarily because most patients present at an advanced stage of the disease. The main cause of this cancer is the bacterium Helicobacter pylori, ...

Diseases, Conditions, Syndromes

Research says H. pylori needs much closer attention

It was long thought that gastric ulcers and other digestive woes were brought about by stress. But in 2005, clinical fellow Barry J. Marshall and pathologist J. Robin Warren were awarded the Nobel Prize in Physiology or Medicine ...

Diseases, Conditions, Syndromes

Vonoprazan-based triple tx feasible for H. pylori

(HealthDay)—The potassium-competitive acid blocker vonoprazan-based triple therapy seems safe and effective compared with conventional proton pump inhibitor (PPI)-based triple therapy as first-line treatment against Helicobacter ...

Diseases, Conditions, Syndromes

Recommendations updated for H. pylori treatment in adults

(HealthDay)—Recommendations have been updated for treatment of Helicobacter pylori in adults, according to a consensus statement published in the July issue of Gastroenterology.

page 6 from 13